First‐Dose Methylphenidate‐Induced Changes in the Anti‐Saccade Task Performance and Outcome in Adults with Attention‐Deficit/Hyperactivity Disorder
Objective We examined whether the anti‐saccade task (AST) performance after the first methylphenidate (MPH) dose could be associated with subsequent clinical outcome in adults with attention‐deficit/hyperactivity disorder (ADHD). Methods Ninety‐seven drug‐naive DSM‐5 ADHD adults participated in this...
Guardado en:
Autores principales: | Fabrice Duval, Alexis Erb, Marie‐Claude Mokrani, Thomas Weiss, Roberta Carcangiu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wiley
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0a2c861d2a6a4175a4959ca69d172432 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Management of attention-deficit hyperactivity disorder in adults: focus on methylphenidate hydrochloride
por: Rajasree Nair, et al.
Publicado: (2009) -
The impact of synapsin III gene on the neurometabolite level alterations after single-dose methylphenidate in attention-deficit hyperactivity disorder patients
por: Başay Ö, et al.
Publicado: (2016) -
Risk factors for low adherence to methylphenidate treatment in pediatric patients with attention-deficit/hyperactivity disorder
por: Asami Ishizuya, et al.
Publicado: (2021) -
Effects of melatonin in children with attention-deficit/hyperactivity disorder with sleep disorders after methylphenidate treatment
por: Masi G, et al.
Publicado: (2019) -
Social adjustment and family function after drug switch from IR -methylphenidate to OROS-methylphenidate in patients with attention-deficit/hyperactivity disorder
por: Chou WJ, et al.
Publicado: (2018)